UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Mechanism of Action of Phosphodiesterase Type 5 Inhibitors in the Treatment of Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia

European urology, 2013-03, Vol.63 (3), p.506-516

2013

Volltextzugriff (PDF)

Phosphodiesterase (PDE) inhibitors in the treatment of lower urinary tract dysfunction

British journal of clinical pharmacology, 2011-08, Vol.72 (2), p.197-204

2011

Volltextzugriff (PDF)

Anatomy, Physiology, and Pathophysiology of Erectile Dysfunction

Journal of sexual medicine, 2010-01, Vol.7 (1pt2), p.445-475

2010

Volltextzugriff (PDF)

Circulating and Urinary Concentrations of Malondialdehyde in Aging Humans in Health and Disease: Review and Discussion

Biomedicines, 2023-10, Vol.11 (10), p.2744

2023

Volltextzugriff (PDF)

Expression and distribution of the transient receptor potential cationic channel ankyrin 1 (TRPA1) in the human seminal vesicles

Health science reports, 2023-01, Vol.6 (1), p.e987-n/a

2023

Volltextzugriff (PDF)

Fibrotic Diseases of the Human Urinary and Genital Tract: Current Understanding and Potential Strategies for Treatment

Journal of clinical medicine, 2023-07, Vol.12 (14), p.4770

2023

Volltextzugriff (PDF)

Re-evaluation of the immunohistochemical distribution of isoforms of nitric oxide synthase in the human prostate: A light and electron microscopical study

Andrologia, 2021-08, Vol.53 (7), p.e14098

2021

Volltextzugriff (PDF)

Emerging drugs to target lower urinary tract symptomatology (LUTS)/benign prostatic hyperplasia (BPH): focus on the prostate

World journal of urology, 2020-06, Vol.38 (6), p.1423-1435

2020

Volltextzugriff (PDF)

Immunohistochemical Distribution of cAMP- and cGMP-Phosphodiesterase (PDE) Isoenzymes in the Human Prostate

European urology, 2006-04, Vol.49 (4), p.740-745

2006

Volltextzugriff (PDF)

Update on phosphodiesterase (PDE) isoenzymes as pharmacologic targets in urology: present and future

European urology, 2006-12, Vol.50 (6), p.1194-207; discussion 1207

2006

Volltextzugriff (PDF)

Avanafil for the treatment of erectile dysfunction: initial data and clinical key properties

Therapeutic Advances in Urology, 2013-02, Vol.5 (1), p.35-41

2013

Volltextzugriff (PDF)

Effects of Phosphodiesterase Inhibitors on Tension Induced by Norepinephrine and Accumulation of Cyclic Nucleotides in Isolated Human Prostatic Tissue

Urology (Ridgewood, N.J.), 2008-03, Vol.71 (3), p.526-530

2008

Volltextzugriff (PDF)

The nitric oxide pathway in the human prostate: clinical implications in men with lower urinary tract symptoms

World journal of urology, 2008-12, Vol.26 (6), p.603-609

2008

Volltextzugriff (PDF)

The role of phosphodiesterases in bladder pathophysiology

Nature reviews. Urology, 2013-07, Vol.10 (7), p.414-424

2013

Volltextzugriff (PDF)

Cyclic nucleotide metabolism including nitric oxide and phosphodiesterase-related targets in the lower urinary tract

Handbook of experimental pharmacology, 2011 (202), p.527

2011

Volltextzugriff (PDF)

Phosphodiesterase type 1, calcitonin gene-related peptide and vasoactive intestinal polypeptide are involved in the control of human vaginal arterial vessels

European journal of obstetrics & gynecology and reproductive biology, 2013-07, Vol.169 (2), p.283-286

2013

Volltextzugriff (PDF)

Effects of Phosphodiesterase Inhibitors on Contraction Induced by Endothelin-1 of Isolated Human Prostatic Tissue

Urology (Ridgewood, N.J.), 2009-06, Vol.73 (6), p.1397-1401

2009

Volltextzugriff (PDF)

The Use of Vasoactive Drugs in the Treatment of Male Erectile Dysfunction: Current Concepts

Journal of clinical medicine, 2020-09, Vol.9 (9), p.2987

2020

Volltextzugriff (PDF)

CHARACTERIZATION AND FUNCTIONAL RELEVANCE OF CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ISOENZYMES OF THE HUMAN PROSTATE

The Journal of urology, 2001-12, Vol.166 (6), p.2484-2490

2001

Volltextzugriff (PDF)

Exposure of Human Seminal Vesicle Tissue to Phosphodiesterase (PDE) Inhibitors Antagonizes the Contraction Induced by Norepinephrine and Increases Production of Cyclic Nucleotides

Urology (Ridgewood, N.J.), 2010-12, Vol.76 (6), p.1518.e1-1518.e6

2010

Volltextzugriff (PDF)

Effects of Phosphodiesterase Inhibitors on the Contractile Responses of Isolated Human Seminal Vesicle Tissue to Adrenergic Stimulation

Journal of sexual medicine, 2009-02, Vol.6 (2), p.408-414

2009

Volltextzugriff (PDF)

Arginase enzymes in the human prostate: expression of arginase isoenzymes and effects of arginase inhibitors on isolated human prostate tissue

BJU international, 2012-12, Vol.110 (11c), p.E1196-E1201

2012

Volltextzugriff (PDF)

Rho Kinase (ROK)‐Related Proteins in Human Cavernous Arteries: An Immunohistochemical and Functional Approach

Journal of sexual medicine, 2012-05, Vol.9 (5), p.1337-1343

2012

Volltextzugriff (PDF)

Characterization of the Effects of Various Drugs Likely to Affect Smooth Muscle Tension on Isolated Human Seminal Vesicle Tissue

Urology (Ridgewood, N.J.), 2010-04, Vol.75 (4), p.974-978

2010

Volltextzugriff (PDF)

S-Nitroso-N-acetyl-L-cysteine ethyl ester (SNACET) and N-acetyl-L-cysteine ethyl ester (NACET)–Cysteine-based drug candidates with unique pharmacological profiles for oral use as NO, H2S and GSH suppliers and as antioxidants: Results and overview

Journal of pharmaceutical analysis, 2018-02, Vol.8 (1), p.1-9

2018

Volltextzugriff (PDF)

1 – 25 von 208

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(203)
Mit Volltextzugriff
(133)

Publikationsform

Sprache

Englisch
(207)
Japanisch
(17)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

The Journal Of Urology
(42)
World Journal Of Urology
(26)
Urology
(24)
Journal Of Sexual Medicine
(15)
European Urology
(10)
The journal Of Urology/the journal Of Urology
(10)
Food Security
(8)
Urolithiasis
(8)
Urological Research
(8)
Regional Environmental Change
(5)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

The Mechanism of Action of Phosphodiesterase Type 5 Inhibitors in the Treatment of Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia

Phosphodiesterase (PDE) inhibitors in the treatment of lower urinary tract dysfunction

Anatomy, Physiology, and Pathophysiology of Erectile Dysfunction

Circulating and Urinary Concentrations of Malondialdehyde in Aging Humans in Health and Disease: Review and Discussion

Expression and distribution of the transient receptor potential cationic channel ankyrin 1 (TRPA1) in the human seminal vesicles

Fibrotic Diseases of the Human Urinary and Genital Tract: Current Understanding and Potential Strategies for Treatment

Re-evaluation of the immunohistochemical distribution of isoforms of nitric oxide synthase in the human prostate: A light and electron microscopical study

Emerging drugs to target lower urinary tract symptomatology (LUTS)/benign prostatic hyperplasia (BPH): focus on the prostate

Immunohistochemical Distribution of cAMP- and cGMP-Phosphodiesterase (PDE) Isoenzymes in the Human Prostate

Update on phosphodiesterase (PDE) isoenzymes as pharmacologic targets in urology: present and future

Avanafil for the treatment of erectile dysfunction: initial data and clinical key properties

Effects of Phosphodiesterase Inhibitors on Tension Induced by Norepinephrine and Accumulation of Cyclic Nucleotides in Isolated Human Prostatic Tissue

The nitric oxide pathway in the human prostate: clinical implications in men with lower urinary tract symptoms

The role of phosphodiesterases in bladder pathophysiology

Cyclic nucleotide metabolism including nitric oxide and phosphodiesterase-related targets in the lower urinary tract

Phosphodiesterase type 1, calcitonin gene-related peptide and vasoactive intestinal polypeptide are involved in the control of human vaginal arterial vessels

Effects of Phosphodiesterase Inhibitors on Contraction Induced by Endothelin-1 of Isolated Human Prostatic Tissue

The Use of Vasoactive Drugs in the Treatment of Male Erectile Dysfunction: Current Concepts

CHARACTERIZATION AND FUNCTIONAL RELEVANCE OF CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ISOENZYMES OF THE HUMAN PROSTATE

Exposure of Human Seminal Vesicle Tissue to Phosphodiesterase (PDE) Inhibitors Antagonizes the Contraction Induced by Norepinephrine and Increases Production of Cyclic Nucleotides

Effects of Phosphodiesterase Inhibitors on the Contractile Responses of Isolated Human Seminal Vesicle Tissue to Adrenergic Stimulation

Arginase enzymes in the human prostate: expression of arginase isoenzymes and effects of arginase inhibitors on isolated human prostate tissue

Rho Kinase (ROK)‐Related Proteins in Human Cavernous Arteries: An Immunohistochemical and Functional Approach

Characterization of the Effects of Various Drugs Likely to Affect Smooth Muscle Tension on Isolated Human Seminal Vesicle Tissue

S-Nitroso-N-acetyl-L-cysteine ethyl ester (SNACET) and N-acetyl-L-cysteine ethyl ester (NACET)–Cysteine-based drug candidates with unique pharmacological profiles for oral use as NO, H2S and GSH suppliers and as antioxidants: Results and overview

Suchergebnisse filtern